Company / Tangible Book Value per Share
Amphstar Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$16.49
FY2025
5-year range
$9.31 / $16.49
FY2021-FY2025
Trend
+8.7%
vs FY2024
Sector context
#31 of 209
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s tangible book value per share of $16.49 is higher than 85% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has increased for 7 consecutive years, from $7.05 in FY2018 to $16.49 in FY2025.
Based on SEC 10-K filings.
16.49 in FY2025 with a 5-year CAGR of +14.0%. Top quartile in the Health Care sector.
Improved from $13.22 to $16.49 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +14.4%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
-82.4% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s tangible book value per share has grown for 7 consecutive years.
- In FY2025, tangible book value per share increased 8.7% year-over-year.
- Ranks #31 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.49 | +8.7% |
| FY2024 | $15.17 | +14.7% |
| FY2023 | $13.22 | +20.1% |
| FY2022 | $11.01 | +18.3% |
| FY2021 | $9.31 | +8.9% |
| FY2020 | $8.55 | +5.6% |
| FY2019 | $8.10 | +15.0% |
| FY2018 | $7.05 | -1.0% |
| FY2017 | $7.12 | -1.1% |
| FY2016 | $7.20 | +10.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026